<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1804200054
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2020
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ANGIRAM
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        RAMIPRIL
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        32.65
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Aurobindo Pharma Limited Unit XV" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Aurobindo Pharma Limited Unit XV
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 3103]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Aurobindo Pharma Saudi Arabia Limited
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Aurobindo Pharma Saudi Arabia Limited
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C09AA05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Angiram contains a medicine called Ramipril. This belongs to a group of medicines called ACE inhibitors (Angiotensin Converting Enzyme Inhibitors).</p><p><strong>Angiram works by:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp; Decreasing your body&rsquo;s production of substances that could raise your blood pressure.</p><p>&middot;&nbsp;&nbsp;&nbsp; Making your blood vessels relax and widen.</p><p>&middot;&nbsp;&nbsp;&nbsp; Making it easier for your heart to pump blood around your body.</p><p><strong>Angiram can be used:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp; To treat high blood pressure (hypertension)</p><p>&middot;&nbsp;&nbsp;&nbsp; To reduce the risk of you having a heart attack or stroke</p><p>&middot;&nbsp;&nbsp;&nbsp; To reduce the risk or delay the worsening of kidney problems (whether or not you have diabetes)</p><p>&middot;&nbsp;&nbsp;&nbsp; To treat your heart when it cannot pump enough blood to the rest of your body (heart failure)</p><p>&middot;&nbsp;&nbsp;&nbsp; As treatment following heart attack (myocardial infarction) complicated with heart failure.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Angiram</strong></p><p>&middot;&nbsp;&nbsp;&nbsp; If you are allergic to ramipril, any other ACE inhibitor medicine or any of the ingredients of this medicine listed in section 6.</p><p>&middot;&nbsp;&nbsp;&nbsp; Signs of an allergic reaction may include a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue.</p><p>&middot;&nbsp;&nbsp;&nbsp; If you have ever had a serious allergic reaction called &ldquo;angioedema&rdquo;. The signs include itching, hives (urticaria), red marks on the hands, feet and throat, swelling of the throat and tongue, swelling around the eyes and lips, difficulty breathing and swallowing.</p><p>&middot;&nbsp;&nbsp;&nbsp; If you are having dialysis or any other type of blood filtration. Depending on the machine that is used, Angiram may not be suitable for you.</p><p>&middot;&nbsp;&nbsp;&nbsp; If you have kidney problems where the blood supply to your kidney is reduced (renal artery stenosis).</p><p>&middot;&nbsp;&nbsp;&nbsp; During the last 6 months of pregnancy.</p><p>&middot;&nbsp;&nbsp;&nbsp; If your blood pressure is abnormally low or unstable. Your doctor will need to make this assessment.</p><p>&middot;&nbsp;&nbsp;&nbsp; If you have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren.</p><p>Do not take Angiram if any of the above apply to you. If you are not sure, talk to your doctor before taking Angiram.</p><p>&nbsp;</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor or pharmacist before taking Angiram:</p><p>&middot;&nbsp;&nbsp;&nbsp; If you have heart, liver or kidney problems</p><p>&middot;&nbsp;&nbsp;&nbsp; If you have lost a lot of body salts or fluids [through being sick (vomiting), having diarrhoea, sweating more than usual, being on a low salt diet, taking diuretics (water tablets) for a long time or having had dialysis].</p><p>&middot;&nbsp;&nbsp;&nbsp; If you are going to have treatment to reduce your allergy to bee or wasp stings (desensitization).</p><p>&middot;&nbsp;&nbsp;&nbsp; If you are going to receive an anaesthetic. This may be given for an operation or any dental work. You may need to stop your Angiram treatment one day beforehand; ask your doctor for advice.</p><p>&middot;&nbsp;&nbsp;&nbsp; If you have high amounts of potassium in your blood (shown in blood test results).</p><p>&middot;&nbsp;&nbsp;&nbsp; If you are taking medicines or have conditions which may decrease sodium levels in your blood. Your doctor may carry out regular blood tests, particularly for checking the levels of sodium in your blood especially if you are elderly.</p><p>&middot;&nbsp;&nbsp;&nbsp; If you are taking medicines called mTOR inhibitors (e.g. temsirolimus, everolimus, sirolimus) or vildagliptin or racecadotril as they may increase the risk of angioedema, a serious allergic reaction.</p><p>&middot;&nbsp;&nbsp;&nbsp; If you have collagen vascular disease such as scleroderma or systemic lupus erythematosus.</p><p>&middot;&nbsp;&nbsp;&nbsp; You must tell your doctor if you think that you are (or might become) pregnant. Angiram is not recommended in the first 3 months of pregnancy and may cause serious harm to your baby after 3 months of pregnancy.</p><p>&middot;&nbsp;&nbsp;&nbsp; If you are taking any of the following medicines used to treat high blood pressure:</p><p>o&nbsp; an angiotensin II receptor blocker (ARBs) (also known as sartans-for example valsartan, telmisartan, irbesartan), in particular if you have diabetes-related kidney problems.</p><ul><li>Aliskiren</li></ul><p>Your doctor may check your kidney function, blood pressure, and the amount of electrolytes (e.g. potassium) in your blood at regular intervals. See also information under the heading &ldquo;Do not take Angiram&rdquo;.</p><p>&nbsp;</p><p><strong>Children and adolescents</strong></p><p>Angiram is not recommended for use in children and adolescents below 18 years of age because the safety and efficacy of Angiram in children has not yet been established.</p><p>If any of the above apply to you (or you are not sure), talk to your doctor before taking Angiram.</p><p>Other medicines and Angiram</p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This is because Angiram can affect the way some other medicines work. Also some medicines can affect the way Angiram works.</p><p>&nbsp;</p><p>Tell your doctor if you are taking any of the following medicines. They can make Angiram work less well:</p><p>&middot;&nbsp;&nbsp;&nbsp; Medicines used to relieve pain and inflammation (e.g. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) such as ibuprofen or indometacin and aspirin).</p><p>&middot;&nbsp;&nbsp;&nbsp; Medicines used for the treatment of low blood pressure, shock, cardiac failure, asthma or allergies such as ephedrine, noradrenaline or adrenaline. Your doctor will need to check your blood pressure.</p><p>&nbsp;</p><p>Tell your doctor if you are taking any of the following medicines. They can increase the chance of getting side effects if you take them with Angiram:</p><p>&middot;&nbsp;&nbsp;&nbsp; Medicines used to relieve pain and inflammation (e.g. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) such as ibuprofen or indometacin and aspirin).</p><p>&middot;&nbsp;&nbsp;&nbsp; Medicines for cancer (chemotherapy)</p><p>&middot;&nbsp;&nbsp;&nbsp; Medicines to stop the rejection of organs after a transplant such as ciclosporin</p><p>&middot;&nbsp;&nbsp;&nbsp; Diuretics (water tablets) such as furosemide</p><p>&middot;&nbsp;&nbsp;&nbsp; Medicines which can increase the amount of potassium in your blood such as spironolactone, triamterene, amiloride, potassium salts, trimethoprim alone or in combination with sulfamethoxazole (for infections) and heparin (for thinning blood)</p><p>&middot;&nbsp;&nbsp;&nbsp; Steroid medicines for inflammation such as prednisolone</p><p>&middot;&nbsp;&nbsp;&nbsp; Allopurinol (used to lower the uric acid in your blood)</p><p>&middot;&nbsp;&nbsp;&nbsp; Procainamide (for heart rhythm problems)</p><p>&middot;&nbsp;&nbsp;&nbsp; Temsirolimus (for cancer)</p><p>&middot;&nbsp;&nbsp;&nbsp; Sirolimus, everolimus (for prevention of graft rejection)</p><p>&middot;&nbsp;&nbsp;&nbsp; Vildagliptin (used for treating type 2 diabetes)</p><p>&middot;&nbsp;&nbsp;&nbsp; Racecadotril (used against diarrhoea)</p><p>&middot;&nbsp;&nbsp;&nbsp; Your doctor may need to change your dose and/or to take other precautions if you are taking an angiotensin II receptor blocker (ARB) or aliskiren (see also information under the headings &ldquo;Do not take Angiram&rdquo; and &ldquo;Warnings and precautions&rdquo;).</p><p>&nbsp;</p><p>Tell your doctor if you are taking any of the following medicines. They may be affected by Angiram:</p><p>&middot;&nbsp;&nbsp;&nbsp; Medicines for diabetes such as oral glucose lowering medicines and insulin. Angiram may lower your blood sugar amounts. Check your blood sugar amounts closely while taking Angiram.</p><p>&middot;&nbsp;&nbsp;&nbsp; Lithium (for mental health problems). Angiram may increase the amount of lithium in your blood. Your lithium amount will need to be closely checked by your doctor.</p><p>If any of the above apply to you (or you are not sure), talk to your doctor before taking Angiram.</p><p><strong>Angiram with food and alcohol</strong></p><p>&middot;&nbsp;&nbsp;&nbsp; Drinking alcohol with Angiram may make you feel dizzy or light-headed. If you are concerned about how much you can drink while you are taking Angiram, discuss this with your doctor as medicines used to reduce blood pressure and alcohol can have additive effects.</p><p>&middot;&nbsp;&nbsp;&nbsp; Angiram may be taken with or without food.</p><p><strong>Pregnancy and breast-feeding</strong></p><p><strong><em>Pregnancy</em></strong></p><p>You must tell your doctor if you think that you are (or might become) pregnant.</p><p>You should not take Angiram in the first 12 weeks of pregnancy and you must not take them at all after the 13<sup>th</sup> week as their use during pregnancy may possibly be harmful to the baby. If you become pregnant while on Angiram, tell your doctor immediately. A switch to a suitable alternative treatment should be carried out in advance of a planned pregnancy.</p><p><strong><em>Breast-feeding</em></strong></p><p>You should not take Angiram if you are breast-feeding. Ask your doctor or pharmacist for advice before taking any medicine.</p><p><strong>Driving and using machines</strong></p><p>You may feel dizzy, while taking Angiram. This is more likely to happen when you start taking angiram or start taking a higher dose. If this happens, do not drive or use any tools or machines.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.</p><p>How much to take</p><p><strong><em>Treatment of high blood pressure</em></strong></p><p>&middot;&nbsp;&nbsp;&nbsp; The usual starting dose is 1.25 mg or 2.5 mg once daily.</p><p>&middot;&nbsp;&nbsp;&nbsp; Your doctor will adjust the amount you take until your blood pressure is controlled.</p><p>&middot;&nbsp;&nbsp;&nbsp; The maximum dose is 10 mg once daily.</p><p>&middot;&nbsp;&nbsp;&nbsp; If you are already taking diuretics (water tablets), your doctor may stop or reduce the amount of the diuretic you take before beginning treatment with Angiram.</p><p>&nbsp;</p><p><strong><em>To reduce the risk of you having a heart attack or stroke</em></strong></p><p>&middot;&nbsp;&nbsp;&nbsp; The usual starting dose is 2.5 mg once daily.</p><p>&middot;&nbsp;&nbsp;&nbsp; Your doctor may then decide to increase the amount you take.</p><p>&middot;&nbsp;&nbsp;&nbsp; The usual dose is 10 mg once daily.</p><p>&nbsp;</p><p><strong><em>Treatment to reduce or delay the worsening of kidney problems</em></strong></p><p>&middot;&nbsp;&nbsp;&nbsp; You may be started on a dose of 1.25 mg or 2.5 mg once daily.</p><p>&middot;&nbsp;&nbsp;&nbsp; Your doctor will adjust the amount you are taking.</p><p>&middot;&nbsp;&nbsp;&nbsp; The usual dose is 5 mg or 10 mg once daily.</p><p><em>&nbsp;</em></p><p><strong><em>Treatment of heart failure</em></strong></p><p>&middot;&nbsp;&nbsp;&nbsp; The usual starting dose is 1.25 mg once daily.</p><p>&middot;&nbsp;&nbsp;&nbsp; Your doctor will adjust the amount you take.</p><p>&middot;&nbsp;&nbsp;&nbsp; The maximum dose is 10 mg daily. Two administrations per day are preferable.</p><p><em>&nbsp;</em></p><p><strong><em>Treatment after you have had a heart attack</em></strong></p><p>&middot;&nbsp;&nbsp;&nbsp; The usual starting dose is 1.25 mg once daily to 2.5 mg twice daily.</p><p>&middot;&nbsp;&nbsp;&nbsp; Your doctor will adjust the amount you take.</p><p>&middot;&nbsp;&nbsp;&nbsp; The usual dose is 10 mg daily. Two administrations per day are preferable.</p><p><em>&nbsp;</em></p><p><strong><em>Older people</em></strong></p><p>Your doctor will reduce the initial dose and adjust your treatment more slowly.</p><p>Taking this medicine</p><p>Take this medicine by mouth at the same time of the day each day.</p><p>Swallow the tablets whole with liquid.</p><p>Do not crush or chew the tablets.</p><p>If you take more Angiram than you should</p><p>Tell a doctor or go to the nearest hospital casualty department straight away. Do not drive to the hospital, get somebody else to take you or call for an ambulance. Take the medicine pack with you. This is so the doctor knows what you have taken.</p><p>&nbsp;</p><p><strong>If you forget to take Angiram</strong></p><p>&middot;&nbsp;&nbsp;&nbsp; If you miss a dose, take your normal dose when it is next due.</p><p>&middot;&nbsp;&nbsp;&nbsp; Do not take a double dose to make up for a forgotten tablet.</p><p>&nbsp;</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>Stop taking Angiram and see a doctor straight away, if you notice any of the following serious side effects &ndash; you may need urgent medical treatment:</p><p>&middot;&nbsp;&nbsp;&nbsp; Swelling of the face, lips or throat which make it difficult to swallow or breathe, as well as itching and rashes. This could be a sign of a severe allergic reaction to Angiram.</p><p>&middot;&nbsp;&nbsp;&nbsp; Severe skin reactions including rash, ulcers in your mouth, worsening of a pre-existing skin disease, reddening, blistering or detachment of skin (such as Stevens-Johnson syndrome, toxic epidermal necrolysis or erythema multiform).</p><p>&nbsp;</p><p><strong>Tell your doctor immediately if you experience:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp; Faster heart rate, uneven or forceful heartbeat (palpitations), chest pain, tightness in your chest or more serious problems including heart attack and stroke.</p><p>&middot;&nbsp;&nbsp;&nbsp; Shortness of breath or a cough. These could be signs of lung problems.</p><p>&middot;&nbsp;&nbsp;&nbsp; Bruising more easily, bleeding for longer than normal, any sign of bleeding (e.g. bleeding from the gums), purple spots, blotching on the skin or getting infections more easily than usual, sore throat and fever, feeling tired, faint, dizzy or having pale skin. These can be signs of blood or bone marrow problems.</p><p>&middot;&nbsp;&nbsp;&nbsp; Severe stomach pain which may reach through to your back. This could be a sign of pancreatitis (inflammation of the pancreas).</p><p>&middot;&nbsp;&nbsp;&nbsp; Fever, chills, tiredness, loss of appetite, stomach pain, feeling sick, yellowing of your skin or eyes (jaundice). These can be signs of liver problems such as hepatitis (inflammation of the liver) or liver damage.</p><p><strong>Other side effects include:</strong></p><p>Tell your doctor if any of the following gets serious or lasts longer than a few days.</p><p>Common (may affect up to 1 in 10 people)</p><p>&middot;&nbsp;&nbsp;&nbsp; Headache or feeling tired</p><p>&middot;&nbsp;&nbsp;&nbsp; Feeling dizzy. This is more likely to happen when you start taking Angiram or start taking a higher dose</p><p>&middot;&nbsp;&nbsp;&nbsp; Fainting, hypotension (abnormally low blood pressure), especially when you stand or sit up quickly</p><p>&middot;&nbsp;&nbsp;&nbsp; Dry tickly cough, inflammation of your sinuses (sinusitis) or bronchitis, shortness of breath</p><p>&middot;&nbsp;&nbsp;&nbsp; Stomach or gut pain, diarrhoea, indigestion, feeling or being sick</p><p>&middot;&nbsp;&nbsp;&nbsp; Skin rash with or without raised area</p><p>&middot;&nbsp;&nbsp;&nbsp; Chest pain</p><p>&middot;&nbsp;&nbsp;&nbsp; Cramps or pain in your muscles</p><p>&middot;&nbsp;&nbsp;&nbsp; Blood tests showing more potassium than usual in your blood.</p><p><strong>Uncommon (may affect up to 1 in 100 people)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp; Balance problems (vertigo)</p><p>&middot;&nbsp;&nbsp;&nbsp; Itching and unusual skin sensations such as numbness, tingling, pricking, burning or creeping on your skin (paraesthesia)</p><p>&middot;&nbsp;&nbsp;&nbsp; Loss or change in the way things taste</p><p>&middot;&nbsp;&nbsp;&nbsp; Sleep problems</p><p>&middot;&nbsp;&nbsp;&nbsp; Feeling depressed, anxious, more nervous than usual or restless</p><p>&middot;&nbsp;&nbsp;&nbsp; Blocked nose, difficulty breathing or worsening of asthma</p><p>&middot;&nbsp;&nbsp;&nbsp; A swelling in your gut called &ldquo;intestinal angioedema&rdquo; presenting with symptoms like abdominal pain, vomiting and diarrhoea</p><p>&middot;&nbsp;&nbsp;&nbsp; Heartburn, constipation or dry mouth</p><p>&middot;&nbsp;&nbsp;&nbsp; Passing more water (urine) than usual over the day</p><p>&middot;&nbsp;&nbsp;&nbsp; Sweating more than usual</p><p>&middot;&nbsp;&nbsp;&nbsp; Loss or decrease of appetite (anorexia)</p><p>&middot;&nbsp;&nbsp;&nbsp; Increased or irregular heartbeats</p><p>&middot;&nbsp;&nbsp;&nbsp; Swollen arms and legs. This may be a sign of your body holding onto more water than usual Flushing</p><p>&middot;&nbsp;&nbsp;&nbsp; Blurred vision</p><p>&middot;&nbsp;&nbsp;&nbsp; Pain in your joints</p><p>&middot;&nbsp;&nbsp;&nbsp; Fever</p><p>&middot;&nbsp;&nbsp;&nbsp; Sexual inability in men, reduced sexual desire in men or women</p><p>&middot;&nbsp;&nbsp;&nbsp; An increased number of certain white blood cells (eosinophilia) found during a blood test</p><p>&middot;&nbsp;&nbsp;&nbsp; Blood tests showing changes in the way your liver, pancreas or kidneys are working.</p><p><strong>Rare (may affect up to 1 in 1,000 people)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp; Feeling shaky or confused</p><p>&middot;&nbsp;&nbsp;&nbsp; Red and swollen tongue</p><p>&middot;&nbsp;&nbsp;&nbsp; Severe flaking or peeling of the skin, itchy, lumpy rash</p><p>&middot;&nbsp;&nbsp;&nbsp; Nail problems (e.g. loosening or separation of a nail from its bed)</p><p>&middot;&nbsp;&nbsp;&nbsp; Skin rash or bruising</p><p>&middot;&nbsp;&nbsp;&nbsp; Blotches on your skin and cold extremities</p><p>&middot;&nbsp;&nbsp;&nbsp; Red, itchy, swollen or watery eyes</p><p>&middot;&nbsp;&nbsp;&nbsp; Disturbed hearing and ringing in your ears</p><p>&middot;&nbsp;&nbsp;&nbsp; Feeling weak</p><p>&middot;&nbsp;&nbsp;&nbsp; Blood tests showing a decrease in the number of red blood cells, white blood cells or platelets or in the amount of haemoglobin.</p><p><strong>Very rare (may affect up to 1 in 10,000 people)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp; Being more sensitive to the sun than usual.</p><p><strong>Other side effects reported:</strong></p><p>Tell your doctor if any of the following gets serious or lasts longer than a few days.</p><p>&middot;&nbsp;&nbsp;&nbsp; Difficulty concentrating</p><p>&middot;&nbsp;&nbsp;&nbsp; Swollen mouth</p><p>&middot;&nbsp;&nbsp;&nbsp; Blood tests showing too few blood cells in your blood</p><p>&middot;&nbsp;&nbsp;&nbsp; Blood tests showing less sodium than usual in your blood</p><p>&middot;&nbsp;&nbsp;&nbsp; Concentrated urine (dark in colour), feel or are sick, have muscle cramps, confusion and fits which may be due to inappropriate ADH (anti-diuretic hormone) secretion. If you have these symptoms contact your doctor as soon as possible</p><p>&middot;&nbsp;&nbsp;&nbsp; Fingers and toes changing colour when you are cold and then tingling or feeling painful when you warm up (Raynaud&rsquo;s phenomenon)</p><p>&middot;&nbsp;&nbsp;&nbsp; Breast enlargement in men</p><p>&middot;&nbsp;&nbsp;&nbsp; Slowed or impaired reactions</p><p>&middot;&nbsp;&nbsp;&nbsp; Burning sensation</p><p>&middot;&nbsp;&nbsp;&nbsp; Change in the way things smell</p><p>&middot;&nbsp;&nbsp;&nbsp; Hair loss.</p><p>&nbsp;</p><p>Reporting of side effects</p><p>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Do not use this medicine after the expiry date which is stated on the blister or carton after EXP. The expiry date refers to the last day of that month.</p><p>Store below 30&deg;C.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is Ramipril.</p><p>Each uncoated tablet contains 5 mg or 10 mg of Ramipril.</p><p>- The other ingredients are:</p><p>5 mg: Starch Pregelatinized, Lactose Monohydrate, Sodium Hydrogen Carbonate, Croscarmellose Sodium, Red Iron Oxide, Sodium Stearyl Fumarate.</p><p>10 mg: Starch Pregelatinized, Lactose Monohydrate, Sodium Hydrogen Carbonate, Croscarmellose Sodium, Sodium Stearyl Fumarate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Angiram 5: Light pink colored mottled, flat faced bevel edged round uncoated tablet debossed with "H" and "19" separated by score line on one side and plain on other side.
Angiram 10: White to off-white colored, flat faced bevel edged round uncoated tablet debossed with "H" and "20" separated by score line on one side and plain on other side.
Angiram tablets are available in Triple laminated Cold form – Aluminium foil blister pack.
Angiram 5 mg & 10 mg tablets are supplied in 20’s pack (10's Blister x 2).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Manufacturer:</strong></p><p>AUROBINDO PHARMA LIMITED,</p><p>Unit III, Survey No. 313 &amp; 314,</p><p>Bachupally, Bachupally Mandal,</p><p>Medchal-Malkajgiri District,</p><p>Telangana State, India.</p><p><strong>Marketing Authorization Holder:</strong></p><p>Aurobindo Pharma Saudi Arabia Limited</p><p><span style="text-align:unset">Jeddah, Saudi Arabia.</span></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                07/2020
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي أنجيرام على دواء يدعى راميبريل. وهو دواء ينتمي إلى مجموعة العقاقير التي تسمى مثبطات ACE (مثبطات إنزيم تحويل الأنجيوتنسين).</p><p dir="RTL"><strong>يعمل أنجيرام عن طريق:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; خفض إنتاج جسمك من مواد من شأنها أن ترفع ضغط دمك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; جعل أوعيتك الدموية تسترخي وتتوسع.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; جعل من السهل على قلبك ضخ الدم إلى أنحاء جسمك.</p><p dir="RTL">يمكن استخدام أنجيرام في الحالات التالية:</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp; لعلاج ارتفاع ضغط الدم</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; لتقليل خطر إصابتك بأزمة قلبية أو سكتة دماغية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; للحد من مخاطر أو تأخير تفاقم مشاكل الكلى (سواء كان لديك أو لم يكن لديك مرض السكري)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; لعلاج قلبك عندما لا يمكنه ضخ ما يكفي من الدم لبقية الجسم (قصور القلب)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; كعلاج بعد النوبة القلبية (احتشاء عضلة القلب) في الحالات المعقدة مع فشل القلب.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تتناول أنجيرام</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا بالحساسية تجاه راميبريل أو أي دواء مثبط لإنزيم ACE آخر أو أي مكون آخر من مكونات هذا الدواء المدرجة في القسم 6.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; علامات تفاعل الحساسية قد تشمل طفح جلدي، مشكلات في البلع أو التنفس، تورم في شفتيك أو وجهك أو حلقك أو لسانك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت قد عانيت في أي وقت مضى من رد فعل تحسسي خطير يسمى &quot;وذمة وعائية&quot;. وتشمل العلامات؛ حكة، وشرى (أرتكاريا)، وعلامات حمراء على اليدين والقدمين والحلق، وتورم في الحلق واللسان، وتورم حول العينين والشفتين، وصعوبة في التنفس والبلع.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت تخضع لغسيل الكلى أو أي نوع آخر من ترشيح الدم. اعتمادا على الجهاز المستخدم، قد لا يكون أنجيرام مناسبًا بالنسبة لك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كان لديك مشاكل في الكلى حيث تقل إمدادات الدم إلى كليتيك (تضيّق الشريان الكلوي).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; خلال الأشهر الستة الأخيرة من الحمل.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كان ضغط دمك منخفضا أو غير مستقر بشكل غير طبيعي. سيحتاج طبيبك إلى إجراء هذا التقييم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا بداء السكري أو خلل وظائف الكلى، وتخضع للعلاج بدواء مخفض لضغط الدم يحتوي على أليسكيرن.</p><p dir="RTL">لا تتناول أنجيرام إذا كان أي مما سبق ينطبق عليك. إذا كنت غير متأكد مما عليك فعله، تحث إلى طبيبك قبل تناول أنجيرام.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التحذيرات والاحتياطات</strong></p><p dir="RTL">تحدث إلى طبيبك أو الصيدلي قبل تناول أنجيرام.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مشكلات قلبية أو كبدية أو كلوية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت قد فقدت الكثير من أملاح الجسم أو السوائل [من خلال كونك مريضا (التقيؤ)، أو الإسهال، أو التعرق أكثر من المعتاد، أو إتباع نظام غذائي منخفض الملح، أو تناول مدرات البول (أقراص الماء) لفترة طويلة، أو خضعت لغسيل الكلى].</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت ستحصل على علاج لتقليل الحساسية تجاه النحل أو لدغة دبور ( إزالة التحسس).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إن كنت ستخضع للتخدير. قد يحدث هذا من أجل عملية أو أي إجراء خاص بالأسنان. قد تحتاج إلى إيقاف العلاج باستخدام أنجيرام قبل يوم واحد من ذلك؛ اطلب نصيحة طبيبك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كان لديك كميات عالية من البوتاسيوم في دمك (كما يتضح من نتائج اختبار الدم).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت تتناول أدوية أو لديك حالات طبية قد تقلل من مستويات الصوديوم في دمك. قد يقوم طبيبك بإجراء فحوص دم منتظمة، خاصة لفحص مستويات الصوديوم في دمك، خاصة إذا كنت مسنا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت تتناول أدوية تسمى مثبطات mTOR (على سبيل المثال، تيمسيروليموس، إيفروليموس، سيروليموس) أو فيلداجليبتين أو ريسكادوتريل لأنها قد تزيد من خطر الوذمة الوعائية، وهو رد فعل تحسسي خطير.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت مصابا بمرض كولاجين وعائي مثل تصلب الجلد أو الذئبة الحمامية الجهازية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; يجب عليك إخبار طبيبك إذا كنتِ تعتقدين أنك (أو قد تصبحين) حاملا. لا ينصح باستخدام أنجيرام في الأشهر الثلاثة الأولى من الحمل، فهو قد يسبب ضررا خطيرا لطفلك بعد 3 أشهر من الحمل.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت تتناول أي من الأدوية التالية المستخدمة في علاج ضغط الدم المرتفع:</p><p dir="RTL">o&nbsp;&nbsp; حاصر مستقبلات أنجيوتنسين 2 (ARBs) (المعروفة أيضا باسم السارتانات-على سبيل المثال فالسارتان، تلميسارتان، إربيسارتان)، وخاصة إذا كان لديك مشاكل بالكلى مرتبطة بالسكري.</p><ul><li dir="RTL">أليسكيرين</li></ul><p dir="RTL">قد يقوم طبيبك بفحص وظائف الكلى، وضغط الدم، وكمية الشوارد (على سبيل المثال البوتاسيوم) في الدم على فترات منتظمة. انظر أيضا المعلومات تحت عنوان &quot;لا تأخذ أنجيرام&quot;.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأطفال والمراهقين</strong></p><p dir="RTL">لا يوصى باستخدام أنجيرام مع الأطفال أو المراهقين أقل من 18 عام حيث لم تثبت بعد مأومنية وفعالية الدواء بالنسبة لهم.</p><p dir="RTL">إذا كان أي من ما سبق ينطبق عليك (أو لم تكن متأكدا)، تحدث مع طبيبك قبل تناول أنجيرام.</p><p dir="RTL">الأدوية الأخرى ودواء أنجيرام</p><p dir="RTL">أخبر الطبيب أو الصيدلاني إذا كنت تتناول أو تناولت مؤخرًا أو قد تتناول أي أدوية أخرى. ذلك لأن أنجيرام يمكنه أن يؤثر على طريقة عمل بعض الأدوية. كما أن بعض الأدوية يمكنها أن تؤثر على طريقة عمل أنجيرام.</p><p dir="RTL">&nbsp;</p><p dir="RTL">اخبر طبيبك إذا كنت تتناول أيًا من الأدوية التالية. فهي قد تجعل جودة عمل أنجيرام أقل:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الأدوية المستخدمة لتخفيف الألم والالتهاب (مثل الأدوية غير الستيرويدية المضادة للالتهابات (NSAIDs) مثل إيبوبروفين أو إندوميتاسين والأسبرين).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الأدوية المستخدمة لعلاج انخفاض ضغط الدم أو الصدمة أو الفشل القلبي أو الربو أو الحساسية مثل الإيفيدرين أو النورادرينالين أو الأدرينالين. سيحتاج طبيبك إلى فحص ضغط دمك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">اخبر طبيبك إذا كنت تتناول أيًا من الأدوية التالية. فهي قد تزيد من فرصة تعرضك لآثار جانبية إذا كنت تأخذها مع أنجيرام:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الأدوية المستخدمة لتخفيف الألم والالتهاب (مثل الأدوية غير الستيرويدية المضادة للالتهابات (NSAIDs) مثل إيبوبروفين أو إندوميتاسين والأسبرين).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; أدوية علاج السرطان (العلاج الكيميائي)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الأدوية المستخدمة لوقف رفض الأعضاء بعد الزرع مثل السيكلوسبورين</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; مدرات البول (أقراص المياه) مثل فوروسيميد</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الأدوية التي من شأنها أن تزيد من كمية البوتاسيوم في الدم مثل سبيرونولاكتون، ترايمترين، أميلوريد، أملاح البوتاسيوم، ترايمثوبريم سواء وحده أو بالاشتراك مع سلفاميثوكسازول (للعدوى) والهيبارين (لترقق الدم)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الأدوية الستيرويدية لعلاج الالتهاب مثل بريدنيزولون</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; ألوبورينول (يستخدم لخفض حمض اليوريك في الدم)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; بروكايناميد (لمشاكل إيقاع القلب)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تمسيروليموس (للسرطان)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; سيروليموس، إيفروليموس (لمنع رفض الزرعة)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; فيلداجليبتين (يستخدم لعلاج داء السكري من النوع الثاني)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; راسيكادوتريل (يستخدم لعلاج الإسهال)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; قد یحتاج طبیبك إلی تغییر جرعتك و/أو اتخاذ احتیاطات أخرى إذا کنت تتناول حاصرات مستقبلات أنجيوتنسين 2 (ARB) أو ألسكيرن (انظر أیضا المعلومات تحت عنوان &quot;لا تأخذ أنجيرام&quot; و&quot;تحذیرات واحتیاطات&quot;).</p><p dir="RTL">&nbsp;</p><p dir="RTL">اخبر طبيبك إذا كنت تتناول أيًا من الأدوية التالية. فهذه الأدوية قد تتأثر باستخدام أنجيرام:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; أدوية علاج مرض السكري مثل أدوية خفض الجلوكوز الفموية والأنسولين. قد يخفض أنجيرام من كميات السكر في دمك. قم بفحص كميات السكر في دمك عن كثب أثناء تناول أنجيرام.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الليثيوم (لمشاكل الصحة العقلية). قد يؤدي أنجيرام إلى زيادة كمية الليثيوم في دمك. سوف تحتاج إلى فحص كميات الليثيوم لديك عن كثب من قبل الطبيب.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كان أي من ما سبق ينطبق عليك (أو لم تكن متأكدا)، تحدث مع طبيبك قبل تناول أنجيرام.</p><p dir="RTL"><strong>تناول أنجيرام مع الطعام والكحول</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; شرب الكحول مع أنجيرام قد يجعلك تشعر بالدوار أو الدوخة. إذا كنت قلقا بشأن مقدار الكحول الذي يمكنك شربه أثناء تناولك لدواء أنجيرام، ناقش هذا الأمر مع طبيبك حيث أن الأدوية المستخدمة لخفض ضغط الدم والكحول يمكن أن يكون لها تأثيرات مضافة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; سيمكن تناول أنجيرام مع الطعام أو بدونه.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية</strong></p><p dir="RTL"><strong><em>الحمل</em></strong></p><p dir="RTL">يجب عليك إخبار طبيبك إذا كنتِ تعتقدين أنك (أو قد تصبحين) حاملا.</p><p dir="RTL">ينبغي أن لا تتناولين أنجيرام في الأسابيع الـ12 الأولى من الحمل، ويجب ألا تتناوليه على الإطلاق بعد الأسبوع الـ13 حيث أن استخدامه خلال فترة الحمل قد يكون ضارا للطفل. إذا كنتِ حاملا أثناء تعاطيك لدواء أنجيرام، أخبري طبيبك فورا. وينبغي إجراء التحول إلى علاج بديل مناسب قبل الحمل المخطط له.</p><p dir="RTL"><strong><em>الرضاعة</em></strong></p><p dir="RTL">ينبغي عدم تناول أنجيرام أثناء الرضاعة. اطلبي المشورة من الطبيب أو الصيدلي قبل تناول أي دواء.</p><p dir="RTL"><strong>القيادة واستخدام الآلات.</strong></p><p dir="RTL">قد تشعر بالدوار، أثناء تعاطي أنجيرام. ومن المرجح أن يحدث هذا عندما تبدأ في تناول أنجيرام أو عندما تبدأ في تناول جرعة أعلى. إذا حدث ذلك، لا تقود أو تستخدم أي أدوات أو آلات.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">ينبغي عليك دائمًا تناول هذا الدواء بدقة كما أخبرك طبيبك المعالج. ينبغي أن تتحقق من طبيبك أو من الصيدلي إذا لم تكن متأكدًا مما ينبغي عليك فعله.</p><p dir="RTL">الكمية التي يجب تناولها</p><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL"><strong><em>علاج ضغط الدم المرتفع</em></strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; جرعة البداية المعتادة هي 1.25 مجم أو 2.5 مجم مرة واحدة يوميا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; سيقوم طبيبك بتعديل الكمية التي تتناولها إلى أن يتم التحكم في ضغط دمك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الجرعة القصوى هي 10 مجم مرة واحدة يوميا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت تتناول بالفعل أدوية مدرة البول (أقراص الماء)، فقد یوقف طبیبك، أو یقلل من مقدار، مدر البول الذي تتناوله قبل بدء العلاج باستخدام أنجيرام.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><em>لتقليل خطر إصابتك بأزمة قلبية أو سكتة دماغية</em></strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; جرعة البداية المعتادة هي 2.5 مجم مرة واحدة يوميا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; قد يقرر طبيبك بعد ذلك زيادة الكمية الذي تأخذها.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الجرعة المعتادة هي 10 مجم مرة واحدة يوميًا.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><em>العلاج للحد من&nbsp;&nbsp;أو تأخير&nbsp;</em><em>أو</em><em> تدهور مشاكل الكلى</em></strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; يمكن أن تبدأ على جرعة قدرها 1.25 مجم أو 2.5 مجم مرة واحدة يوميا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; سيقوم طبيبك بعد ذلك بتعديل الكمية الذي تتناولها.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الجرعة المعتادة هي 5 مجم أو 10 مجم مرة واحدة يوميًا.</p><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL"><strong><em>علاج فشل القلب.</em></strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; جرعة البداية المعتادة هي 1.25 مجم مرة واحدة يوميًا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; سيقوم طبيبك بعد ذلك بتعديل الكمية الذي تتناولها.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الحد الأقصى للجرعة هو &nbsp;10مجم يوميا. يفضل إعطاء الدواء على جرعتين في اليوم.</p><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL"><strong><em>العلاج بعد التعرض لنوبة قلبية</em></strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; جرعة البداية المعتادة هي 1.25 مجم مرة واحدة يوميًا إلى 2.5 مجم مرتين يوميا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; سيقوم طبيبك بعد ذلك بتعديل الكمية الذي تتناولها.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الجرعة المعتادة هي 10 مجم مرة واحدة يوميًا. يفضل إعطاء الدواء على جرعتين في اليوم.</p><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL"><strong><em>المسنين</em></strong></p><p dir="RTL">سيقوم طبيبك بخفض الجرعة الأولية وضبط علاجك ببطء أكبر.</p><p dir="RTL">تناول هذا الدواء عن طريق الفم في نفس الوقت من اليوم كل يوم.</p><p dir="RTL">ابتلع الأقراص كاملة مع السوائل.</p><p dir="RTL">لا تسحق الأقراص أو تمضغها.</p><p dir="RTL">في حالة تعاطيك جرعة من أنجيرام أكبر مما ينبغي ، أخبر طبيب أو انتقل إلى أقرب قسم إصابات بالمستشفى على الفور. لا تقود السيارة إلى المستشفى، بل اطلب شخص آخر ليأخذك أو اطلب سيارة إسعاف. خذ عبوة الدواء معك. هذا لكي يعرف الطبيب ما قد تناولته.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>في حالة نسيانك تناول أنجيرام</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إن فوت جرعة من الدواء، تناول جرعتك المعتادة التالية في موعدها.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; لا تتناول جرعة مضاعفة لتعويض القرص الذي نسيت تناوله.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كانت لديك أية أسئلة أخرى حول استخدام هذا الدواء، فيمكنك سؤال طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كما هو الحال بالنسبة لجميع الأدوية، قد يسبب هذا الدواء آثارًا جانبية، على الرغم من أنها لا تصيب الجميع.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>توقف عن تناول أنجيرام وقم بزيارة الطبيب على الفور، إذا لاحظت أي من الآثار الجانبية الخطيرة التالية - قد تحتاج إلى علاج طبي عاجل:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تورم في الوجه أو الشفتين أو الحلق مما يجعل من الصعب الابتلاع أو التنفس، بالإضافة إلى الحكة والطفح الجلدي. قد يكون هذا علامة على رد فعل تحسسي شديد تجاه أنجيرام.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; ردود فعل جلدية شديدة تشمل الطفح الجلدي، وقرحة الفم، وتفاقم مرض جلدي موجود مسبقا، واحمرار الجلد، والفقاقيع انفصال الجلد (مثل متلازمة ستيفنز جونسون، أو نخر البشرة السمي أو حمامي عديدة الأشكال).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أخبر طبيبك على الفور إذا أصبت بأي مما يلي:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تسارع معدل ضربات القلب، عدم انتظام أو قوة ضربات القلب (خفقان)، ألم في الصدر، ضيق في صدرك، أو مشاكل أكثر خطورة بما في ذلك النوبة القلبية والسكتة الدماغية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; ضيق في التنفس أو السعال. يمكن أن تكون هذه علامات على مشاكل الرئة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; التكدم بسهولة أكبر، النزيف لفترة أطول من المعتاد، أي علامة على النزف (مثل نزيف اللثة)، بقع أرجوانية، أو تلوث الجلد أو الإصابة بالعدوى بسهولة أكبر من المعتاد، التهاب الحلق والحمى، الشعور بالتعب أو الإرهاق أو الدوار أو شحوب الجلد. يمكن أن تكون هذه علامات على مشاكل في الدم أو نخاع العظام.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; آلام شديدة في المعدة قد تصل إلى ظهرك. هذا يمكن أن يكون علامة على التهاب البنكرياس.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; حمى، قشعريرة، تعب، فقدان الشهية، آلام في المعدة، الشعور بالمرض، اصفرار الجلد أو العينين (اليرقان). هذه يمكن أن تكون علامات على مشاكل الكبد مثل التهاب الكبد أو تلف الكبد.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>آثار جانبية أخرى تشمل:</strong></p><p dir="RTL">أخبر طبيبك إذا أصبح أي من التالي أكثر شدة أو استمر لفترة أطول من بضعة أيام.</p><p dir="RTL">آثار شائعة (قد تؤثر على فرد واحد بحد أقصى بين كل 10 أفراد)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الصداع أو الشعور بالتعب</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الشعور بالدوار. ومن المرجح أن يحدث هذا عندما تبدأ في تناول أنجيرام أو عندما تبدأ في تناول جرعة أعلى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الإغماء، انخفاض ضغط الدم (انخفاض ضغط الدم بشكل غير طبيعي)، وخصوصا عند الوقوف أو الجلوس بسرعة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; السعال الجاف الخشن، أو التهاب الجيوب الأنفية، أو التهاب الشعب الهوائية، وضيق في التنفس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; آلام في المعدة أو الأمعاء، أو الإسهال، أو عسر الهضم، أو الشعور بالمرض</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; طفح جلدي مع أو بدون منطقة مرتفعة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; ألم في الصدر</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تشنجات أو ألم في عضلاتك</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; اختبارات الدم تظهر وجود زيادة من البوتاسيوم أكثر من المعتاد في دمك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>آثار غير شائعة (قد تصيب شخص واحد بحد أقصى من بين كل 100 شخص)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; مشاكل في التوازن (الدوار)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; حكة وأحاسيس غير طبيعية في الجلد مثل الخدر، والتنميل، والوخز، وحرقة في الجلد (مذل)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; فقدان أو تغيير في طعم الأشياء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; مشاكل النوم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الشعور بالاكتئاب، القلق، زيادة العصبية عن المعتاد أو الهياج</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; انسداد الأنف، صعوبة في التنفس، أو تفاقم الربو</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تورم في أمعائك يسمى &quot;وذمة وعائية معوية&quot; يظهر في صورة أعراض مثل آلام في البطن والقيء والإسهال</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; حرقة المعدة، أو الإمساك، أو جفاف الفم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إخراج المزيد من المياه (البول) أكثر من المعتاد خلال اليوم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; التعرق أكثر من المعتاد</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; فقدان أو نقصان الشهية (فقدان الشهية)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; زيادة أو عدم انتظام ضربات القلب</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تورم اليدين والساقين. هذا قد يكون علامة على جسمك يحبس المزيد من المياه من المعتاد توهج الجلد</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تغيُّم الرؤية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; ألم في المفاصل</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; حمى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; فقد القدرة الجنسية لدى الرجال، وانخفاض الرغبة الجنسية لدى الرجال أو النساء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; زيادة عدد خلايا معينة من خلايا الدم البيضاء (كَثْرَةُ اليُوزينِيَّات) وهو ما يثبت أثناء فحص الدم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; اختبارات الدم تظهر تغيرات في طريقة عمل الكبد، أو البنكرياس أو الكلى.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>آثار نادرة جدًا (قد تصيب فرد واحد بين كل 1000 فرد)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الشعور بالرعشة أو الارتباك</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; احمرار وتورم اللسان</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تفتت أو تقشر الجلد بصورة شديدة، حكة، طفح جلدي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; مشاكل الأظافر (مثل ترخي أو فصل الظفر من موضعه)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; طفح جلدي أو تكدم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; بقع على الجلد وبرودة الأطراف</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; احمرار، حكة، تورم أو زيادة إدماع العينين</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; ضعف السمع أو طنين الأذن</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الشعور بالضعف</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; اختبارات الدم تظهر انخفاضا في عدد خلايا الدم الحمراء، أو خلايا الدم البيضاء، أو الصفائح الدموية، أو في كمية الهيموجلوبين.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>آثار نادرة جدا (قد تؤثر على فرد واحد بحد أقصى بين كل 10000 فرد)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تصبح أكثر حساسية للشمس عن المعتاد.</p><p dir="RTL">الآثار الجانبية الأخرى المُبلغ عنها:</p><p dir="RTL">أخبر طبيبك إذا أصبح أي من التالي أكثر شدة أو استمر لفترة أطول من بضعة أيام.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; صعوبة في التركيز</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تورم الفم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; اختبارات الدم تظهر انخفاض كبير في خلايا الدم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; اختبارات الدم تظهر وجود كمية من الصوديوم أقل من المعتاد في دمك</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; البول المركز (ذو اللون الداكن)، الشعور بالمرض أو المرض، تشنجات عضلية، ارتباك ونوبات، والتي قد تكون بسبب الإفراز غير المناسب من هرمون ADH (المضاد لإدرار البول). إذا كانت لديك هذه الأعراض، اتصل بطبيبك في أقرب وقت ممكن</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تغير لون أصابع اليدين والقدمين عندما تشعر بالبرد، ثم تشعر بالوخز أو بالألم عندما تستدفيء (ظاھرة رینود)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تثدي الرجال</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; بطء أو ضعف ردود الفعل</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الشعور بالحرقة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تغيير في طعم الأشياء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تساقط الشعر.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الإبلاغ عن الآثار الجانبية</strong></p><p dir="RTL">إذا تعرضت لأي تأثيرات غير مرغوب فيها، تحدث إلى طبيبك أو الصيدلي أو ممرضتك. يشتمل هذا على أية آثار جانبية محتملة وغير مدرجة في هذه النشرة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احفظ هذا الدواء بعيدًا عن مرأى ومتناول الأطفال</p><p dir="RTL">لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المُدون على العبوة الكرتونية أو شرائط الدواء، بعد الرمز &quot;EXP&quot;. يشير تاريخ الانتهاء إلى آخر يوم من ذلك الشهر.</p><p dir="RTL">يتم تخزينه في درجة حرارة أقل من 30&deg; مئوية.</p><p dir="RTL">يجب عدم التخلص من أي أدوية عبر مياه الصرف أو في المخلفات المنزلية. اسأل الصيدلي عن الطريقة المثلى للتخلص من الأدوية التي لم تعد تستخدمها. ستساهم هذه التدابير في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مكونات أنجيرام</p><p dir="RTL"><strong>المادة الفعالة هي</strong> راميبريل.</p><p dir="RTL">كل قرص غير مغلف يحتوي على 5 مجم أو 10 مجم من راميبريل.</p><p dir="RTL"><strong>- المكونات الأخرى هي:</strong></p><p dir="RTL">5 مجم: بريجيلاتينيزد نشا، مونوهيدرات اللاكتوز، صوديوم هيدروجين كربونات، كروسكارملوس الصوديوم، أكسيد الحديد الأحمر، فوماريت ستياريال الصوديوم.</p><p dir="RTL">10 مجم: بريجيلاتينيزد نشا، مونوهيدرات اللاكتوز، صوديوم هيدروجين كربونات، كروسكارملوس الصوديوم، فوماريت ستياريال الصوديوم.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><u>أنجيرام 5:</u> أقراص غير مغلفة لونها وردي فاتح، مزركشة، مستوية السطحين، مشطوفة الحواف، مستديرة، منقوش عليها &quot;H&quot; و&quot;19&quot; بينهما خطر كسر من جهة ومستوية من الجهة الأخرى.</p><p dir="RTL"><u>أنجيرام 10:</u> أقراص غير مغلفة لونها أبيض إلى أبيض فاتح، مستوية السطحين، مشطوفة الحواف، مستديرة، منقوش عليها &quot;H&quot; و&quot;20&quot; بينهما خطر كسر من جهة ومستوية من الجهة الأخرى.</p><p dir="RTL">تتوفر أقراص أنجيرام في عبوة بها شرائط من رقائق الألومنيوم- في صورة رقائقية ثلاثية باردة.</p><p dir="RTL">تتوفر أقراص أنجيرام 5 مجم و10 مجم في عبوة 30 قرص (3 شرائط بكل شريط منها 10 أقراص).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>الشركة المصنعة:</strong></p><p dir="RTL">أوروبيندو فارما المحدودة.</p><p dir="RTL">الوحدة 3، المنطقة رقم 313 و314،</p><p dir="RTL">بالوبالي، بالوبالي ماندال،</p><p dir="RTL">منطقة ميدال-مالكاجاجيري،</p><p dir="RTL">تيلانجانا، الهند.</p><p dir="RTL"><strong>مالك تصريح التسويق:</strong></p><p dir="RTL">أوروبيندو فارما السعودية المحدودة</p><p dir="RTL"><span style="text-align:unset">جده ، المملكة العربية السعودية.</span></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            07/2020
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Angiram 5 (Ramipril Tablets BP 5 mg)
Angiram 10 (Ramipril Tablets BP 10 mg)
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Ramipril Tablets BP 5 mg:
Each uncoated tablet contains Ramipril Ph.Eur. 5 mg.
Excipients with known effect:
Each tablet contains 21.7 mg Lactose monohydrate.
Ramipril Tablets BP 10 mg:
Each uncoated tablet contains Ramipril Ph.Eur. 10 mg.
Excipients with known effect:
Each tablet contains 43.4 mg Lactose monohydrate.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Ramipril Tablets BP 5 mg: Light pink colored mottled, flat faced bevel edged round uncoated tablet debossed with “H” and “19” separated by score line on one side and plain on other side.
Ramipril Tablets BP 10 mg: White to off-white colored, flat faced bevel edged round uncoated tablet debossed with “H” and “20” separated by score line on one side and plain on other side.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>-&nbsp; Treatment of hypertension.</strong></p><p><strong>-&nbsp; Cardiovascular prevention:</strong> reduction of cardiovascular morbidity and mortality in patients with:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; manifest atherothrombotic cardiovascular disease (history of coronary heart disease or stroke, or peripheral vascular disease) or</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; diabetes with at least one cardiovascular risk factor.</p><p><strong>-&nbsp; Treatment of renal disease:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Incipient glomerular diabetic nephropathy as defined by the presence of microalbuminuria,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Manifest glomerular diabetic nephropathy as defined by macroproteinuria in patients with at least one cardiovascular risk factor,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Manifest glomerular non diabetic nephropathy as defined by macroproteinuria &ge; 3 g/day.</p><p><strong>-&nbsp; Treatment of symptomatic heart failure.</strong></p><p><strong>-&nbsp;&nbsp;Secondary prevention after acute myocardial infarction:</strong> reduction of mortality from the acute phase of myocardial infarction in patients with clinical signs of heart failure when started &gt; 48 hours following acute myocardial infarction.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>It is recommended that Angiram is taken each day at the same time of the day.</p><p>Angiram can be taken before, with or after meals, because food intake does not modify its bioavailability.</p><p>Angiram has to be swallowed with liquid. It must not be chewed or crushed.</p><p><strong><em><u>Adults</u></em></strong></p><p><strong><u>Diuretic-Treated patients</u></strong></p><p>Hypotension may occur following initiation of therapy with ANGIRAM; this is more likely in patients who are being treated concurrently with diuretics. Caution is therefore recommended since these patients may be volume and/or salt depleted.</p><p>If possible, the diuretic should be discontinued 2 to 3 days before beginning therapy with Angiram.</p><p>In hypertensive patients in whom the diuretic is not discontinued, therapy with Angiram should be initiated with a 1.25 mg dose. Renal function and serum potassium should be monitored. The subsequent dose of Angiram should be adjusted according to blood pressure target.</p><p><em>Hypertension</em></p><p>The dose should be individualised according to the patient profile and blood pressure control. Angiram may be used in monotherapy or in combination with other classes of antihypertensive medicinal products.</p><p><u>Starting dose</u></p><p>Angiram should be started gradually with an initial recommended dose of 2.5 mg daily.</p><p>Patients with a strongly activated renin-angiotensin-aldosterone system may experience an excessive drop in blood pressure following the initial dose. A starting dose of 1.25 mg is recommended in such patients and the initiation of treatment should take place under medical supervision.</p><p><u>Titration and maintenance dose</u></p><p>The dose can be doubled at interval of two to four weeks to progressively achieve target blood pressure; the maximum permitted dose of Angiram is 10 mg daily. Usually the dose is administered once daily.</p><p><strong><em>Cardiovascular</em><em> </em><em>prevention</em></strong></p><p><u>Starting dose</u></p><p>The recommended initial dose is 2.5 mg of Angiram once daily. <u>Titration and maintenance dose</u></p><p>Depending on the patient&rsquo;s tolerability to the active substance, the dose should be gradually increased. It is recommended to double the dose after one or two weeks of treatment and - after another two to three weeks &ndash; to increase it up to the target maintenance dose of 10 mg Angiram once daily.</p><p>See also posology on diuretic treated patients above.</p><p><strong><em>Treatment</em><em> </em><em>of</em><em> </em><em>renal</em><em> </em><em>disease</em></strong></p><p><em><u>In patients with diabetes and microalbuminuria:</u></em></p><p><u>Starting dose:</u></p><p>The recommended initial dose is 1.25 mg of Angiram once daily. <u>Titration and maintenance dose</u></p><p>Depending on the patient&rsquo;s tolerability to the active substance, the dose is subsequently increased. Doubling the once daily dose to 2.5 mg after two weeks and then to 5 mg after a further two weeks is recommended.</p><p><em><u>In patients with diabetes and at least one cardiovascular risk</u></em></p><p><u>Starting dose:</u></p><p>The recommended initial dose is 2.5 mg of Angiram once daily.</p><p><u>Titration and maintenance dose</u></p><p>Depending on the patient&rsquo;s tolerability to the active substance, the dose is subsequently increased. Doubling the daily dose to 5 mg Angiram after one or two weeks and then to 10 mg Angiram after a further two or three weeks is recommended. The target daily dose is 10 mg.</p><p><em><u>In patients with non- diabetic nephropathy as defined by macroproteinuria &ge; 3 g/day.</u></em></p><p><u>Starting dose:</u></p><p>The recommended initial dose is 1.25 mg of Angiram once daily.</p><p><u>Titration and maintenance dose</u></p><p>Depending on the patient&rsquo;s tolerability to the active substance, the dose is subsequently increased. Doubling the once daily dose to 2.5 mg after two weeks and then to 5 mg after a further two weeks is recommended.</p><p><strong><em>Symptomatic heart failure</em></strong></p><p><u>Starting dose</u></p><p>In patients stabilized on diuretic therapy, the recommended initial dose is 1.25 mg daily. <u>Titration and maintenance dose</u></p><p>Angiram should be titrated by doubling the dose every one to two weeks up to a maximum daily dose of 10 mg. Two administrations per day are preferable.</p><p><strong><em>Secondary prevention after acute myocardial infarction and with heart failure</em></strong></p><p><u>Starting dose</u></p><p>After 48 hours, following myocardial infarction in a clinically and haemodynamically stable patient, the starting dose is 2.5 mg twice daily for three days. If the initial 2.5 mg dose is not tolerated a dose of 1.25 mg twice a day should be given for two days before increasing to 2.5 mg and 5 mg twice a day. If the dose cannot be increased to 2.5 mg twice a day the treatment should be withdrawn.</p><p>See also posology on diuretic treated patients above. <u>Titration and maintenance dose</u></p><p>The daily dose is subsequently increased by doubling the dose at intervals of one to three days up to the target maintenance dose of 5 mg twice daily.</p><p>The maintenance dose is divided in 2 administrations per day where possible.</p><p>If the dose cannot be increased to 2.5 mg twice a day treatment should be withdrawn. Sufficient experience is still lacking in the treatment of patients with severe (NYHA IV) heart failure immediately after myocardial infarction. Should the decision be taken to treat these patients, it is recommended that therapy be started at 1.25 mg once daily and that particular caution be exercised in any dose increase.</p><p><strong><em><u>Special populations</u></em></strong></p><p><strong><em>Patients with renal impairment</em></strong></p><p>Daily dose in patients with renal impairment should be based on creatinine:</p><p>-&nbsp; if creatinine clearance is &ge; 60 ml/min, it is not necessary to adjust the initial dose (2.5 mg/day); the maximal daily dose is 10 mg;</p><p>-&nbsp;&nbsp; if creatinine clearance is between 30-60 ml/min, it is not necessary to adjust the initial dose (2.5 mg/day); the maximal daily dose is 5 mg;</p><p>-&nbsp;&nbsp; if creatinine clearance is between 10-30 ml/min, the initial dose is 1.25 mg/day and the maximal daily dose is 5 mg;</p><p>-&nbsp;&nbsp;&nbsp; in haemodialysed hypertensive patients: ramipril is slightly dialysable; the initial dose is 1.25 mg/day and the maximal daily dose is 5 mg; the medicinal product should be administered few hours after haemodialysis is performed.</p><p><strong><em>Patients with hepatic impairment</em></strong></p><p>In patients with hepatic impairment, treatment with Angiram must be initiated only under close medical supervision and the maximum daily dose is 2.5 mg ANGIRAM.</p><p><strong><em>Elderly</em></strong></p><p>Initial doses should be lower and subsequent dose titration should be more gradual because of greater chance of undesirable effects especially in very old and frail patients. A reduced initial dose of 1.25 mg ramipril should be considered.</p><p><strong><em>Paediatric population</em></strong></p><p>The safety and efficacy of ramipril in children has not yet been established. Currently available data for Angiram are described in sections 4.8, 5.1, 5.2 &amp; 5.3 but no specific recommendation on posology can be made.</p><p><strong><u>Method of administration</u> </strong></p><p>Oral use.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                •	Hypersensitivity to the active substance, to any of the excipients listed in section 6.1 or any other ACE (Angiotensin Converting Enzyme) inhibitors.
•	History of angioedema (hereditary, idiopathic or due to previous angioedema with ACE inhibitors or AIIRAs)
•	Concomitant use with sacubitril/valsartan therapy (see sections 4.4 and 4.5).
•	Extracorporeal treatments leading to contact of blood with negatively charged surfaces (see section 4.5)
•	Significant bilateral renal artery stenosis or renal artery stenosis in a single functioning kidney.
•	Second and third trimesters of pregnancy (see sections 4.4 and 4.6)
•	Ramipril must not be used in patients with hypotensive or haemodynamically unstable states.
•	The concomitant use of Angiram with aliskiren-containing products is contraindicated in patients with diabetes mellitus or renal impairment (GFR < 60 ml/min/1.73m2) (see sections 4.5 and 5.1).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Special populations</u></strong></p><p><strong><em><u>Pregnancy</u></em></strong></p><p>ACE inhibitors such as ramipril or Angiotensin II Receptor Antagonists (AIIRAs) should not be initiated during pregnancy. Unless continued ACE inhibitor/AIIRAs therapy is considered essential, patients planning pregnancy should be changed to alternative anti-hypertensive treatments which have an established safety profile for use in pregnancy. When pregnancy is diagnosed, treatment with ACE inhibitors/AIIRAs should be stopped immediately, and, if appropriate, alternative therapy should be started (see sections 4.3 and 4.6).</p><p><strong><em><u>Patients at particular risk of hypotension</u></em></strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Patients with strongly activated renin-angiotensin-aldosterone system</em></p><p>Patients with strongly activated renin-angiotensin-aldosterone system are at risk of an acute pronounced fall in blood pressure and deterioration of renal function due to ACE inhibition, especially when an ACE inhibitor or a concomitant diuretic is given for the first time or at first dose increase.</p><p>Significant activation of renin-angiotensin-aldosterone system is to be anticipated and medical supervision including blood pressure monitoring is necessary, for example in:</p><p>-&nbsp; patients with severe hypertension</p><p>-&nbsp; patients with decompensated congestive heart failure</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; patients with haemodynamically relevant left ventricular inflow or outflow impediment (e.g. stenosis of the aortic or mitral valve)</p><p>-&nbsp; patients with unilateral renal artery stenosis with a second functional kidney</p><p>-&nbsp; patients in whom fluid or salt depletion exists or may develop (including patients with diuretics)</p><p>-&nbsp; patients with liver cirrhosis and/or ascites</p><p>-&nbsp; patients undergoing major surgery or during anaesthesia with agents that produce hypotension.</p><p>Generally, it is recommended to correct dehydration, hypovolaemia or salt depletion before initiating treatment (in patients with heart failure, however, such corrective action must be carefully weighed out against the risk of volume overload).</p><p>&bull;&nbsp; <em>Dual</em><em> </em><em>blockade of the renin-angiotensin-aldosterone system (RAAS)</em></p><p>There is evidence that the concomitant use of ACE-inhibitors, angiotensin II receptor blockers or aliskiren increases the risk of hypotension, hyperkalaemia and decreased renal function (including acute renal failure). Dual blockade of RAAS through the combined use of ACE-inhibitors, angiotensin II receptor blockers or aliskiren is therefore not recommended (see sections 4.5 and 5.1). If dual blockade therapy is considered absolutely necessary, this should only occur under specialist supervision and subject to frequent close monitoring of renal function, electrolytes and blood pressure.</p><p>ACE-inhibitors and angiotensin II receptor blockers should not be used concomitantly in patients with diabetic nephropathy.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Transient</em><em> </em><em>or persistent heart failure post MI</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Patients at risk of cardiac or cerebral ischemia in case of acute hypotension</em></p><p>The initial phase of treatment requires special medical supervision.</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><em>Elderly</em></p><p>See section 4.2.</p><p><strong><u>Surgery</u></strong></p><p>It is recommended that treatment with angiotensin converting enzyme inhibitors such as ramipril should be discontinued where possible one day before surgery.</p><p><strong><u>Monitoring of renal function</u></strong></p><p>Renal function should be assessed before and during treatment and dose adjusted especially in the initial weeks of treatment. Particularly careful monitoring is required in patients with renal impairment (see section 4.2). There is a risk of impairment of renal function, particularly in patients with congestive heart failure or after a renal transplant.</p><p><strong><u>Angioedema</u></strong></p><p>Angioedema has been reported in patients treated with ACE inhibitors including ramipril (see section 4.8). This risk of angioedema may be increased in patients taking concomitant medications which may cause angioedema such as mTOR (mammalian target of rapamycin) inhibitors (e.g. temsirolimus, everolimus, sirolimus), vildagliptin or neprilysin (NEP) inhibitors (such as racecadotril).. The combination of ramipril with sacubitril/valsartan is contraindicated due to the increased risk of angioedema (see sections 4.3 and 4.5).</p><p>In case of angioedema, Angiram must be discontinued.</p><p>Emergency therapy should be instituted promptly. Patient should be kept under observation for at least 12 to 24 hours and discharged after complete resolution of the symptoms.</p><p>Intestinal angioedema has been reported in patients treated with ACE inhibitors including Angiram (see section 4.8). These patients presented with abdominal pain (with or without nausea or vomiting).</p><p><strong><u>Anaphylactic reactions during desensitization</u></strong></p><p>The likelihood and severity of anaphylactic and anaphylactoid reactions to insect venom and other allergens are increased under ACE inhibition. A temporary discontinuation of Angiram should be considered prior to desensitization.</p><p><strong><u>Electrolyte Monitoring: Hyperkalaemia</u></strong></p><p>Hyperkalaemia has been observed in some patients treated with ACE inhibitors including ANGIRAM. Patients at risk for development of hyperkalaemia include those with renal insufficiency, age (&gt; 70 years), uncontrolled diabetes mellitus, or those using potassium salts, potassium retaining diuretics and other plasma potassium increasing active substances, or conditions such as dehydration, acute cardiac decompensation, metabolic acidosis. If concomitant use of the above mentioned agents is deemed appropriate, regular monitoring of serum potassium is recommended (see section 4.5).</p><p><strong><u>Electrolyte Monitoring: Hyponatraemia</u></strong></p><p>Syndrome of Inappropriate Anti-diuretic Hormone (SIADH) and subsequent hyponatraemia has been observed in some patients treated with ramipril. It is recommended that serum sodium levels be monitored regularly in the elderly and in other patients at risk of hyponatraemia.</p><p><strong><u>Neutropenia/agranulocytosis</u></strong></p><p>Neutropenia/agranulocytosis, as well as thrombocytopenia and anaemia, have been rarely seen and bone marrow depression has also been reported. It is recommended to monitor the white blood cell count to permit detection of a possible leucopoenia. More frequent monitoring is advised in the initial phase of treatment and in patients with impaired renal function, those with concomitant collagen disease (e.g. lupus erythematosus or scleroderma), and all those treated</p><p>with other medicinal products that can cause changes in the blood picture (see sections 4.5 and 4.8).</p><p><u><strong>Ethnic </strong>differences</u></p><p>ACE inhibitors cause higher rate of angioedema in black patients than in non-black patients.</p><p>As with other ACE inhibitors, ramipril may be less effective in lowering blood pressure in black people than in non-black patients, possibly because of a higher prevalence of hypertension with low renin level in the black hypertensive population.</p><p><strong><u>Cough</u></strong></p><p>Cough has been reported with the use of ACE inhibitors. Characteristically, the cough is nonproductive, persistent and resolves after discontinuation of therapy. ACE inhibitor-induced cough should be considered as part of the differential diagnosis of cough.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Clinical trial data has shown that dual blockade of the renin-angiotensin-aldosterone-system (RAAS) through the combined use of ACE-inhibitors, angiotensin II receptor blockers or aliskiren is associated with a higher frequency of adverse events such as hypotension, hyperkalaemia and decreased renal function (including acute renal failure) compared to the use of a single RAAS-acting agent (see sections 4.3, 4.4 and 5.1).</p><p><u>Contra-indicated combinations</u></p><p>The concomitant use of ACE inhibitors with sacubitril/valsartan is contraindicated as this increases the risk of angioedema (see sections 4.3 and 4.4). Treatment with ramipril must not be started until 36 hours after taking the last dose of sacubitril/valsartan. Sacubitril/valsartan must not be started until 36 hours after the last dose of Angiram.</p><p>Extracorporeal treatments leading to contact of blood with negatively charged surfaces such as dialysis or haemofiltration with certain high-flux membranes (e.g. polyacrylonitril membranes) and low density lipoprotein apheresis with dextran sulphate due to increased risk of severe anaphylactoid reactions (see section 4.3). If such treatment is required, consideration should be given to using a different type of dialysis membrane or a different class of antihypertensive agent.</p><p><u>Precautions for use</u></p><p><em>Potassium salts, heparin, potassium-retaining diuretics and other plasma potassium increasing active substances (including Angiotensin II antagonists, trimethoprim and in fixed dose combination with sulfamethoxazole, tacrolimus, ciclosporin):</em></p><p>Hyperkalaemia may occur, therefore close monitoring of serum potassium is required. <em>Antihypertensive agents (e.g. diuretics) and other substances that may decrease blood pressure (e.g. nitrates, tricyclic antidepressants, anaesthetics, acute alcohol intake, baclofen, alfuzosin, doxazosin, prazosin, tamsulosin, terazosin):</em></p><p>Potentiation of the risk of hypotension is to be anticipated (see section 4.2 for diuretics)</p><p><em>Vasopressor sympathomimetics and other substances (e.g. isoproterenol, dobutamine, dopamine, epinephrine) that may reduce the antihypertensive effect of </em>ANGIRAM:</p><p>Blood pressure monitoring is recommended.</p><p><em>Allopurinol, immunosuppressants, corticosteroids, procainamide, cytostatics and other substances that may change the blood cell count:</em></p><p>Increased likelihood of haematological reactions (see section 4.4).</p><p><em>Lithium</em><em> </em><em>salts:</em></p><p>Excretion of lithium may be reduced by ACE inhibitors and therefore lithium toxicity may be increased. Lithium level must be monitored.</p><p><em>Antidiabetic agents including insulin:</em></p><p>Hypoglycaemic reactions may occur. Blood glucose monitoring is recommended.</p><p><em>Non-steroidal anti-inflammatory drugs and acetylsalicylic acid:</em></p><p>Reduction of the antihypertensive effect of Angiram is to be anticipated. Furthermore, concomitant treatment of ACE inhibitors and NSAIDs may lead to an increased risk of worsening of renal function and to an increase in kalaemia.</p><p><em>mTOR</em><em> </em><em>inhibitors or DPP-IV inhibitors</em>:</p><p>An increased risk of angioedema is possible in patients taking concomitant medications such as mTOR inhibitors (e.g. temsirolimus, everolimus, sirolimus) or vildagliptin. Caution should be used when starting therapy (see section 4.4).</p><p><em>Neprilysin (NEP) inhibitors:</em></p><p>An increased risk of angioedema has been reported with concomitant use of ACE inhibitors and NEP inhibitor such as racecadotril (see section 4.4).</p><p><em>Sacubitril/valsartan</em></p><p>The concomitant use of ACE inhibitors with sacubitril/valsartan is contraindicated as this increases the risk of angioedema.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Pregnancy</u></strong></p><table border="1" cellspacing="1" cellpadding="1" style="width:626px"><tbody><tr><td style="width:623px"><p>ANGIRAM is not recommended during the first trimester of pregnancy (see section 4.4) and is contraindicated during the second and third trimesters of pregnancy (see section 4.3).</p></td></tr></tbody></table><p>Epidemiological evidence regarding the risk of teratogenicity following exposure to ACE inhibitors during the first trimester of pregnancy has not been conclusive; however a small increase in risk cannot &nbsp;be &nbsp;excluded. &nbsp;Unless &nbsp;continued &nbsp;ACE &nbsp;inhibitor &nbsp;therapy &nbsp;is &nbsp;considered &nbsp;essential, &nbsp;patients planning pregnancy should be changed to alternative antihypertensive treatments which have an established safety profile for use in pregnancy. When pregnancy is diagnosed, treatment with ACE inhibitors should be stopped immediately, and, if appropriate, alternative therapy should be started.</p><p>ACE inhibitor/Angiotensin II Receptor Antagonist (AIIRA) therapy exposure during the second and third trimesters is known to induce human foetotoxicity (decreased renal function, oligohydramnios, skull ossification retardation) and neonatal toxicity (renal failure, hypotension, hyperkalaemia) (See section 5.3 &ldquo;Preclinical safety data&rdquo;). Should exposure to ACE inhibitors have occurred from the second trimester of pregnancy, ultrasound check of renal function and skull is recommended. Newborns whose mothers have taken ACE inhibitors should be closely observed for hypotension, oliguria and hyperkalaemia (see also sections 4.3 and 4.4).</p><p><strong><u>Breast-feeding</u></strong></p><p>Because insufficient information is available regarding the use of ramipril during breastfeeding (see section 5.2), Angiram is not recommended and alternative treatments with better established safety profiles during breast-feeding are preferable, especially while nursing a newborn or preterm infant.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Some adverse effects (e.g. symptoms of a reduction in blood pressure such as dizziness) may impair the patient&rsquo;s ability to concentrate and react and, therefore, constitute a risk in situations where these abilities are of particular importance (e.g. operating a vehicle or machinery).</p><p>This can happen especially at the start of treatment, or when changing over from other preparations. After the first dose or subsequent increases in dose it is not advisable to drive or operate machinery for several hours.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Summary of safety profile</em></p><p>The safety profile of ramipril includes persistent dry cough and reactions due to hypotension. Serious adverse reactions include angioedema, hyperkalaemia, renal or hepatic impairment, pancreatitis, severe skin reactions and neutropenia/agranulocytosis.</p><p><em>Tabulated</em><em> </em><em>list of adverse reactions</em></p><p>Adverse reactions frequency is defined using the following convention:</p><p>Very common (&ge; 1/10); common (&ge; 1/100 to &lt; 1/10); uncommon (&ge; 1/1,000 to &lt; 1/100); rare (&ge; 1/10,000 to &lt; 1/1,000); very rare (&lt; 1/10,000), not known (cannot be estimated from the available data).</p><p>&nbsp;</p><p>Within &nbsp;each &nbsp;frequency &nbsp;grouping, &nbsp;undesirable &nbsp;effects &nbsp;are &nbsp;presented &nbsp;in &nbsp;order &nbsp;of &nbsp;decreasing seriousness.</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p><strong>Common</strong></p></td><td style="vertical-align:top"><p><strong>Uncommon</strong></p></td><td style="vertical-align:top"><p><strong>Rare</strong></p></td><td style="vertical-align:top"><p><strong>Very</strong><strong> </strong><strong>rare</strong></p></td><td style="vertical-align:top"><p><strong>Not known</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Blood and lymphatic system disorders</em></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Eosinophilia</p></td><td style="vertical-align:top"><p>White blood cell count decreased&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (including</p><p>neutropenia&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or</p><p>agranulocytosis), red blood cell count</p><p>decreased, haemoglobin decreased, platelet count decreased</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Bone marrow</p><p>failure, pancytopenia, haemolytic anaemia</p></td></tr><tr><td style="vertical-align:top"><p><em>Immune system disorders</em></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Anaphylactic&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or anaphylactoid</p><p>reactions,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; antinuclear antibody increased</p></td></tr><tr><td style="vertical-align:top"><p><em>Endocrine</em><em> </em><em>disorders</em></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Syndrome&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; of</p><p>inappropriate</p><p>antidiuretic&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hormone secretion (SIADH)</p></td></tr><tr><td style="vertical-align:top"><p><em>Metabolism</em><em> </em><em>and nutrition disorders</em></p></td><td style="vertical-align:top"><p>Blood potassium increased</p></td><td style="vertical-align:top"><p>Anorexia, decreased appetite,</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Blood sodium decreased</p></td></tr><tr><td style="vertical-align:top"><p><em>Psychiatric</em><em> </em><em>disorders</em></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Depressed&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; mood, anxiety,</p><p>nervousness, restlessness,&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sleep disorder&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; including somnolence</p></td><td style="vertical-align:top"><p>Confusional state</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Disturbance in attention</p></td></tr><tr><td style="vertical-align:top"><p><em>Nervous system disorders</em></p></td><td style="vertical-align:top"><p>Headache, dizziness</p></td><td style="vertical-align:top"><p>Vertigo, paraesthesia, ageusia,</p><p>dysgeusia,</p></td><td style="vertical-align:top"><p>Tremor, balance disorder</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Cerebral&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;ischaemia</p><p>including ischaemic stroke and transient ischaemic&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; attack,</p><p>psychomotor&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skills impaired,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; burning sensation, parosmia</p></td></tr><tr><td style="vertical-align:top"><p><em>Eye disorders</em></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Visual disturbance including blurred vision</p></td><td style="vertical-align:top"><p>Conjunctivitis</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><em>Ear and labyrinth disorders</em></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Hearing impaired, tinnitus</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><em>Cardiac disorders</em></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Myocardial &nbsp;ischaemia including angina pectoris or myocardial infarction,</p><p>tachycardia, arrhythmia,palpitation s,oedema peripheral</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><em>Vascular disorders</em></p></td><td style="vertical-align:top"><p>Hypotensio n, Orthostatic blood pressure decreased, syncope</p></td><td style="vertical-align:top"><p>Flushing</p></td><td style="vertical-align:top"><p>Vascular stenosis, hypoperfusion, vasculitis</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Raynaud&rsquo;s phenomenon</p></td></tr><tr><td style="vertical-align:top"><p><em>Respiratory, thoracic and mediastinal disorders</em></p></td><td style="vertical-align:top"><p>Non- productive tickling cough, bronchitis, sinusitis, dyspnoea</p></td><td style="vertical-align:top"><p>Bronchospasm including&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; asthma aggravated, nasal congestion</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><em>Gastrointestin</em><em> </em><em>al</em></p><p><em>disorders</em></p></td><td style="vertical-align:top"><p>Gastrointes tinal inflammati on, digestive disturbance s, abdominal discomfort, dyspepsia, diarrhoea, nausea, vomiting</p></td><td style="vertical-align:top"><p>Pancreatitis (cases of fatal outcome have been&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; very</p><p>exceptionally reported with ACE inhibitors), pancreatic</p><p>Enzymes increased, small&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; bowel</p><p>angioedema, abdominal pain upper including&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; gastritis, constipation,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dry mouth</p></td><td style="vertical-align:top"><p>Glossitis</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Aphtous Stomatitis</p></td></tr><tr><td style="vertical-align:top"><p><em>Hepatobiliary</em><em> </em><em>disorders</em></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Hepatic&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; enzymes</p><p>and/or&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; bilirubin conjugated increased,</p></td><td style="vertical-align:top"><p>Jaundice&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cholestatic, hepatocellular</p><p>damage</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Acute hepatic failure, cholestatic or cytolytic hepatitis&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (fatal outcome has been very exceptional).</p></td></tr><tr><td style="vertical-align:top"><p><em>Skin and subcutaneous tissue disorders</em></p></td><td style="vertical-align:top"><p>Rash&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; in particular maculo- papular</p></td><td style="vertical-align:top"><p>Angioedema;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;very</p><p>exceptionally, the airway</p><p>Obstruction resulting from angioedema may have a fatal outcome; pruritus, hyperhidrosis</p></td><td style="vertical-align:top"><p>Exfoliative&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dermatitis, urticaria, onycholysis,</p></td><td style="vertical-align:top"><p>Photose nsitivity reaction</p></td><td style="vertical-align:top"><p>Toxic&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; epidermal necrolysis,&nbsp; Stevens- Johnson&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; syndrome, Erythema multiforme, pemphigus, psoriasis aggravated, dermatitis psoriasiform, pemphigoid&nbsp;&nbsp; or lichenoid&nbsp;&nbsp; exanthema or&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; enanthema, alopecia</p></td></tr><tr><td style="vertical-align:top"><p><em>Musculoskelet</em><em> </em><em>al</em></p><p><em>and connective tissue disorders</em></p></td><td style="vertical-align:top"><p>Muscle spasms, myalgia</p></td><td style="vertical-align:top"><p>Arthralgia</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><em>Renal and urinary disorders</em></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Renal impairment including renal failure acute, urine output increased, worsening of a pre-existing proteinuria, blood urea increased,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blood creatinine increased</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><em>Reproductive</em><em> </em><em>system and breast disorders</em></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Transient&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; erectile</p><p>impotence,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; libido decreased</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Gynaecomastia</p></td></tr><tr><td style="vertical-align:top"><p><em>General disorders and</em></p><p><em>administration</em><em> </em><em>site conditions</em></p></td><td style="vertical-align:top"><p>Chest&nbsp; pain, fatigue</p></td><td style="vertical-align:top"><p>Pyrexia</p></td><td style="vertical-align:top"><p>Asthenia</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p><u>Paediatric population</u></p><p>The safety of ramipril was monitored in 325 children and adolescents, aged 2-16 years old, during 2 clinical trials. Whilst the nature and severity of the adverse events are similar to that of the adults, the frequency of the following is higher in the children:</p><p>Tachycardia, nasal congestion and rhinitis, &ldquo;common&rdquo; (i.e, &ge; 1/100 to &lt; 1/10) in paediatric, and &ldquo;uncommon&rdquo; (i.e. &ge; 1/1,000 to &lt; 1/100) in adult population.</p><p>Conjunctivitis &ldquo;common&rdquo; (i.e, &ge; 1/100 to &lt;&nbsp; 1/10) in paediatric and &ldquo;rare&rdquo; (i.e. &ge; 1/10,000 to &lt;</p><p>1/1,000) in adult population.</p><p>Tremor and urticaria &ldquo;uncommon&rdquo; (.i.e. &ge; 1/1,000 to &lt; 1/100) in paediatric population and &ldquo;rare&rdquo; (i.e. &ge; 1/10,000 to &lt;1/1,000) in adult population.</p><p>The overall safety profile for ramipril in paediatric patients does not differ significantly from the safety profile in adults.</p><p>&nbsp;</p><p>To report any side effect(s):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Saudi Arabia:</em></p><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td><p>-&nbsp;&nbsp; The National Pharmacovigilance and Drug Safety Center (NPC)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Fax: +966-11-205-7662</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Center: 19999</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Toll free phone: 8002490000</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;E-mail: npc.drug@sfda.gov.sa</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Website: www.sfda.gov.sa/npc</p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Symptoms</p><p>Symptoms associated with overdose of ACE inhibitors may include excessive peripheral vasodilation (with marked hypotension, shock), bradycardia, electrolyte disturbances and renal failure.</p><p>Management</p><p>The patient should be closely monitored and the treatment should be symptomatic and supportive. Suggested measures include primary detoxification (gastric lavage, administration of adsorbents) and measures to restore haemodynamic stability, including, administration of alpha 1 adrenergic agonists or angiotensin II (angiotensinamide) administration.</p><p>Ramiprilat, the active metabolite of ramipril is poorly removed from the general circulation by haemodialysis.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: ACE Inhibitors, plain, ATC code C09AA05.</p><p><strong><u>Mechanism of action</u></strong></p><p>Ramiprilat, the active metabolite of the prodrug ramipril, inhibits the enzyme dipeptidyl carboxypeptidase I (synonyms: angiotensin-converting enzyme; kininase II). In plasma and tissue this enzyme catalyses the conversion of angiotensin I to the active vasoconstrictor substance angiotensin II, as well as the breakdown of the active vasodilator bradykinin. Reduced angiotensin II formation and inhibition of bradykinin breakdown lead to vasodilatation.</p><p>Since angiotensin II also stimulates the release of aldosterone, ramiprilat causes a reduction in aldosterone secretion. The average response to ACE inhibitor monotherapy was lower in black (Afro-Caribbean) hypertensive patients (usually a low-renin hypertensive population) than in non- black patients.</p><p><strong><u>Pharmacodynamic effects</u> </strong></p><p>Antihypertensive properties:</p><p>Administration of ramipril causes a marked reduction in peripheral arterial resistance. Generally, there are no major changes in renal plasma flow and glomerular filtration rate. Administration of ramipril to patients with hypertension leads to a reduction in supine and standing blood pressure without a compensatory rise in heart rate.</p><p>In most patients the onset of the antihypertensive effect of a single dose becomes apparent 1 to 2 hours after oral administration. The peak effect of a single dose is usually reached 3 to 6 hours after oral administration. The antihypertensive effect of a single dose usually lasts for 24 hours.</p><p>The maximum antihypertensive effect of continued treatment with ramipril is generally apparent after 3 to 4 weeks. It has been shown that the antihypertensive effect is sustained under long term therapy lasting 2 years.</p><p>Abrupt discontinuation of ramipril does not produce a rapid and excessive rebound increase in blood pressure.</p><p>Heart failure:</p><p>In addition to conventional therapy with diuretics and optional cardiac glycosides, ramipril has been shown to be effective in patients with functional classes II-IV of the New-York Heart Association. The drug had beneficial effects on cardiac haemodynamics (decreased left and right ventricular filling pressures, reduced total peripheral vascular resistance, increased cardiac output and improved cardiac index). It also reduced neuroendocrine activation.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>1.1&nbsp; <u>Absorption</u></strong></p><p>Following oral administration ramipril is rapidly absorbed from the gastrointestinal tract: peak plasma concentrations of ramipril are reached within one hour. Based on urinary recovery, the extent of absorption is at least 56 % and is not significantly influenced by the presence of food in the gastrointestinal tract. The bioavailability of the active metabolite ramiprilat after oral administration of 2.5 mg and 5 mg ramipril is 45 %.</p><p>Peak plasma concentrations of ramiprilat, the sole active metabolite of ramipril are reached 2-4 hours after Ramipril intake. Steady state plasma concentrations of ramiprilat after once daily dosing with the usual doses of ramipril are reached by about the fourth day of treatment.</p><p><strong><u>Distribution</u></strong></p><p>The serum protein binding of ramipril is about 73 % and that of ramiprilat about 56 %.</p><p><strong><u>Biotransformation</u></strong></p><p>Ramipril is almost completely metabolised to ramiprilat, and to the diketopiperazine ester, the diketopiperazine acid, and the glucuronides of ramipril and ramiprilat.</p><p><strong><u>Elimination</u></strong></p><p>Excretion of the metabolites is primarily renal.</p><p>Plasma concentrations of ramiprilat decline in a polyphasic manner. Because of its potent, saturable binding to ACE and slow dissociation from the enzyme, ramiprilat shows a prolonged terminal elimination phase at very low plasma concentrations.</p><p>After multiple once-daily doses of ramipril, the effective half-life of ramiprilat concentrations was 13-17 hours for the 5-10 mg doses and longer for the lower 1.25-2.5 mg doses. This difference is related to the saturable capacity of the enzyme to bind ramiprilat.</p><p>Patients with renal impairment (see section 4.2)</p><p>Renal excretion of ramiprilat is reduced in patients with impaired renal function, and renal ramiprilat clearance is proportionally related to creatinine clearance. This results in elevated plasma concentrations of ramiprilat, which decrease more slowly than in subjects with normal renal function.</p><p>Patients with hepatic impairment (see section 4.2)</p><p>In patients with impaired liver function, the metabolism of ramipril to ramiprilat was delayed, due to diminished activity of hepatic esterases, and plasma ramipril levels in these patients were increased. Peak concentrations of ramiprilat in these patients, however, are not different from those seen in subjects with normal hepatic function.</p><p><strong><em>Lactation</em></strong></p><p>A single oral dose of ramipril produced an undetectable level of ramipril and its metabolite in breast milk. However the effect of multiple doses is not known.</p><p><strong><em>Paediatric Population</em></strong></p><p>The pharmacokinetic profile of ramipril was studied in 30 paediatric hypertensive patients, aged 2- 16 years, weighing &ge; 10kg. After doses of 0.05 to 0.2mg/kg, ramipril was rapidly and extensively metabolized to ramiprilat. Peak plasma concentrations of ramiprilat occurred within 2-3 hours. Ramiprilat clearance highly correlated with the log of body weight (p&lt;0.01) as well as dose (p&lt;0.001). Clearance and volume of distribution increased with increasing children age for each dose group. The dose of 0.05mg/kg in children achieved exposure levels comparable to those in adults treated with ramipril 5mg. The dose of 0.2mg/kg in children resulted in exposure levels higher than the maximum recommended dose of 10mg per day in adults.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Oral administration of ramipril has been found to be devoid of acute toxicity in rodents and dogs. Studies involving chronic oral administration have been conducted in rats, dogs and monkeys. Indications of plasma electrolyte shifts and changes in blood picture have been found in the 3 species. As an expression of the pharmacodynamic activity of ramipril, pronounced enlargement of the juxtaglomerular apparatus has been noted in the dog and monkey from daily doses of 250 mg/kg/d.</p><p>Rats, dogs and monkeys tolerated daily doses of 2, 2.5 and 8 mg/kg/d respectively without harmful effects.</p><p>Reproduction toxicology studies in the rat, rabbit and monkey did not disclose any teratogenic properties.</p><p>Fertility was not impaired either in male or in female rats.</p><p>The administration of ramipril to female rats during the fetal period and lactation produced irreversible renal damage (dilatation of the renal pelvis) in the offspring at daily doses of 50 mg/kg body weight or higher.</p><p>Extensive mutagenicity testing using several test systems has yielded no indication that ramipril possesses mutagenic or genotoxic properties.</p><p>Irreversible kidney damage has been observed in very young rats given a single dose of ramipril.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>5 mg: Starch Pregelatinized, Lactose Monohydrate, Sodium Hydrogen Carbonate, Croscarmellose Sodium, Red Iron Oxide, Sodium Stearyl Fumarate.</p><p>10 mg: Starch Pregelatinized, Lactose Monohydrate, Sodium Hydrogen Carbonate, Croscarmellose Sodium, Sodium Stearyl Fumarate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Angiram 5 mg &amp; 10 mg tablets are supplied in 20&rsquo;s pack (10&rsquo;s Blister x 2).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not Applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Aurobindo Pharma Saudi Arabia Limited, 
Jeddah, Saudi Arabia.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                07/2019
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>